OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities
Kyuho Han, Sarah E. Pierce, Amy Li, et al.
Nature (2020) Vol. 580, Iss. 7801, pp. 136-141
Open Access | Times Cited: 262
Kyuho Han, Sarah E. Pierce, Amy Li, et al.
Nature (2020) Vol. 580, Iss. 7801, pp. 136-141
Open Access | Times Cited: 262
Showing 1-25 of 262 citing articles:
High-content CRISPR screening
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 367
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 367
Cell–extracellular matrix mechanotransduction in 3D
Aashrith Saraswathibhatla, Dhiraj Indana, Ovijit Chaudhuri
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 7, pp. 495-516
Open Access | Times Cited: 315
Aashrith Saraswathibhatla, Dhiraj Indana, Ovijit Chaudhuri
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 7, pp. 495-516
Open Access | Times Cited: 315
CRISPR in cancer biology and therapy
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 290
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 290
Organoid Models of Tumor Immunology
Kanako Yuki, Ning Cheng, Michitaka Nakano, et al.
Trends in Immunology (2020) Vol. 41, Iss. 8, pp. 652-664
Open Access | Times Cited: 287
Kanako Yuki, Ning Cheng, Michitaka Nakano, et al.
Trends in Immunology (2020) Vol. 41, Iss. 8, pp. 652-664
Open Access | Times Cited: 287
Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet
Andreas Bender, Isidro Cortés‐Ciriano
Drug Discovery Today (2020) Vol. 26, Iss. 2, pp. 511-524
Open Access | Times Cited: 226
Andreas Bender, Isidro Cortés‐Ciriano
Drug Discovery Today (2020) Vol. 26, Iss. 2, pp. 511-524
Open Access | Times Cited: 226
Tumor organoids: Opportunities and challenges to guide precision medicine
Vivien Veninga, Emile E. Voest
Cancer Cell (2021) Vol. 39, Iss. 9, pp. 1190-1201
Closed Access | Times Cited: 207
Vivien Veninga, Emile E. Voest
Cancer Cell (2021) Vol. 39, Iss. 9, pp. 1190-1201
Closed Access | Times Cited: 207
High-content CRISPR screening
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 203
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 203
3D Culture Models with CRISPR Screens Reveal Hyperactive NRF2 as a Prerequisite for Spheroid Formation via Regulation of Proliferation and Ferroptosis
Nobuaki Takahashi, Patricia Cho, Laura M. Selfors, et al.
Molecular Cell (2020) Vol. 80, Iss. 5, pp. 828-844.e6
Open Access | Times Cited: 152
Nobuaki Takahashi, Patricia Cho, Laura M. Selfors, et al.
Molecular Cell (2020) Vol. 80, Iss. 5, pp. 828-844.e6
Open Access | Times Cited: 152
Synthetic Lethality in Cancer Therapeutics: The Next Generation
Jeremy Setton, Michael Zinda, Nadeem Riaz, et al.
Cancer Discovery (2021) Vol. 11, Iss. 7, pp. 1626-1635
Open Access | Times Cited: 142
Jeremy Setton, Michael Zinda, Nadeem Riaz, et al.
Cancer Discovery (2021) Vol. 11, Iss. 7, pp. 1626-1635
Open Access | Times Cited: 142
The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation
Timothy D. Martin, Rupesh S. Patel, Danielle Cook, et al.
Science (2021) Vol. 373, Iss. 6561, pp. 1327-1335
Closed Access | Times Cited: 130
Timothy D. Martin, Rupesh S. Patel, Danielle Cook, et al.
Science (2021) Vol. 373, Iss. 6561, pp. 1327-1335
Closed Access | Times Cited: 130
A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation
Yuan‐Hung Lo, Kevin S. Kolahi, Yuhong Du, et al.
Cancer Discovery (2021) Vol. 11, Iss. 6, pp. 1562-1581
Open Access | Times Cited: 116
Yuan‐Hung Lo, Kevin S. Kolahi, Yuhong Du, et al.
Cancer Discovery (2021) Vol. 11, Iss. 6, pp. 1562-1581
Open Access | Times Cited: 116
CRISPR screens in physiologic medium reveal conditionally essential genes in human cells
Nicholas J. Rossiter, Kimberly S. Huggler, Charles H. Adelmann, et al.
Cell Metabolism (2021) Vol. 33, Iss. 6, pp. 1248-1263.e9
Open Access | Times Cited: 111
Nicholas J. Rossiter, Kimberly S. Huggler, Charles H. Adelmann, et al.
Cell Metabolism (2021) Vol. 33, Iss. 6, pp. 1248-1263.e9
Open Access | Times Cited: 111
Targeting and engineering long non-coding RNAs for cancer therapy
Michela Coan, Simon Haefliger, Samir Ounzain, et al.
Nature Reviews Genetics (2024) Vol. 25, Iss. 8, pp. 578-595
Closed Access | Times Cited: 64
Michela Coan, Simon Haefliger, Samir Ounzain, et al.
Nature Reviews Genetics (2024) Vol. 25, Iss. 8, pp. 578-595
Closed Access | Times Cited: 64
Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models
Ornella Urzì, Roberta Gasparro, Elisa Costanzo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12046-12046
Open Access | Times Cited: 48
Ornella Urzì, Roberta Gasparro, Elisa Costanzo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12046-12046
Open Access | Times Cited: 48
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa T. Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 44
Roel Polak, Elisa T. Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 44
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy
Suman Mukhopadhyay, Hsin‐Yi Huang, Ziyan Lin, et al.
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4095-4111
Open Access | Times Cited: 42
Suman Mukhopadhyay, Hsin‐Yi Huang, Ziyan Lin, et al.
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4095-4111
Open Access | Times Cited: 42
Applications of organoids for cancer biology and precision medicine
Yuan‐Hung Lo, Kasper Karlsson, Calvin J. Kuo
Nature Cancer (2020) Vol. 1, Iss. 8, pp. 761-773
Open Access | Times Cited: 132
Yuan‐Hung Lo, Kasper Karlsson, Calvin J. Kuo
Nature Cancer (2020) Vol. 1, Iss. 8, pp. 761-773
Open Access | Times Cited: 132
Characterizing the ecological and evolutionary dynamics of cancer
Nastaran Zahir, Ruping Sun, Daniel Gallahan, et al.
Nature Genetics (2020) Vol. 52, Iss. 8, pp. 759-767
Closed Access | Times Cited: 124
Nastaran Zahir, Ruping Sun, Daniel Gallahan, et al.
Nature Genetics (2020) Vol. 52, Iss. 8, pp. 759-767
Closed Access | Times Cited: 124
Anti-Inflammation Activity of Flavones and Their Structure–Activity Relationship
Xiang Wang, Yujia Cao, Siyu Chen, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 26, pp. 7285-7302
Closed Access | Times Cited: 100
Xiang Wang, Yujia Cao, Siyu Chen, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 26, pp. 7285-7302
Closed Access | Times Cited: 100
Air−Liquid Interface Cultures of the Healthy and Diseased Human Respiratory Tract: Promises, Challenges, and Future Directions
Domizia Baldassi, Bettina Gabold, Olivia M. Merkel
Advanced NanoBiomed Research (2021) Vol. 1, Iss. 6
Open Access | Times Cited: 96
Domizia Baldassi, Bettina Gabold, Olivia M. Merkel
Advanced NanoBiomed Research (2021) Vol. 1, Iss. 6
Open Access | Times Cited: 96
The ECM: To Scaffold, or Not to Scaffold, That Is the Question
Jonard Corpuz Valdoz, Benjamin C. Johnson, Dallin J. Jacobs, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12690-12690
Open Access | Times Cited: 90
Jonard Corpuz Valdoz, Benjamin C. Johnson, Dallin J. Jacobs, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12690-12690
Open Access | Times Cited: 90
Heterogeneous microenvironmental stiffness regulates pro-metastatic functions of breast cancer cells
Chunying Liu, Miao Li, Zhaoxia Dong, et al.
Acta Biomaterialia (2021) Vol. 131, pp. 326-340
Open Access | Times Cited: 89
Chunying Liu, Miao Li, Zhaoxia Dong, et al.
Acta Biomaterialia (2021) Vol. 131, pp. 326-340
Open Access | Times Cited: 89
Decellularised scaffolds: just a framework? Current knowledge and future directions
Elena García‐Gareta, Yousef Abduldaiem, Prasad Sawadkar, et al.
Journal of Tissue Engineering (2020) Vol. 11
Open Access | Times Cited: 84
Elena García‐Gareta, Yousef Abduldaiem, Prasad Sawadkar, et al.
Journal of Tissue Engineering (2020) Vol. 11
Open Access | Times Cited: 84
Metabolic precision labeling enables selective probing of O-linked N -acetylgalactosamine glycosylation
Marjoke F. Debets, Ömür Y. Tastan, Simon Wisnovsky, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 41, pp. 25293-25301
Open Access | Times Cited: 70
Marjoke F. Debets, Ömür Y. Tastan, Simon Wisnovsky, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 41, pp. 25293-25301
Open Access | Times Cited: 70
MISpheroID: a knowledgebase and transparency tool for minimum information in spheroid identity
Arne Peirsman, Eva Blondeel, Tasdiq Ahmed, et al.
Nature Methods (2021) Vol. 18, Iss. 11, pp. 1294-1303
Open Access | Times Cited: 60
Arne Peirsman, Eva Blondeel, Tasdiq Ahmed, et al.
Nature Methods (2021) Vol. 18, Iss. 11, pp. 1294-1303
Open Access | Times Cited: 60
